Patents by Inventor Ravi Malaviya

Ravi Malaviya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MESH-LINK TRAFFIC SEGMENTATION BASED ON PRIORITY
    Publication number: 20240089798
    Abstract: A root access point (RAP) that communicates with one or more mesh access points (MAPs) via two or more concurrent mesh links (or paths) in a mesh network is described. Notably, during operation, the RAP may communicate, via a mesh link in the two or more concurrent mesh links, packets or frames with the one or more MAPs, where the mesh link uses a band of frequencies, and where the packets or frames have a priority. Moreover, the RAP may communicate, via a second mesh link in the two or more concurrent mesh links, second packets or second frames with the one or more MAPs, where the second mesh link uses a second band of frequencies that is different from the currently selected band of frequencies, and where the second packets or second frames have a second priority that is less than the priority of the packets or frames.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 14, 2024
    Applicant: ARRIS Enterprises LLC
    Inventors: Ravi Kiran Mattaparti, Hemant Bhatnagar, Virendra Malaviya
  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20230340155
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 26, 2023
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Antibodies that specifically bind PD-1 and methods of use
    Patent number: 11746161
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: September 5, 2023
    Assignee: Janssen Biotech, Inc.
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Antibodies that specifically bind PD-1 and methods of use
    Patent number: 10995149
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: May 4, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20210102000
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 8, 2021
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • ST2L antagonists and methods of use
    Patent number: 10450377
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: October 22, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • ST2L ANTAGONISTS AND METHODS OF USE
    Publication number: 20190062439
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 28, 2019
    Inventors: Karen DUFFY, Natalie Pursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20180355061
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: June 4, 2018
    Publication date: December 13, 2018
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yavegniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • ST2L antagonists and methods of use
    Patent number: 9951137
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: April 24, 2018
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • ST2L Antagonists and Methods of Use
    Publication number: 20170066831
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: November 12, 2015
    Publication date: March 9, 2017
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
    Patent number: 9212227
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: December 15, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • ST2L antibody antagonists
    Patent number: 9090694
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: July 28, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiun Wu
  • ST2L Antagonists and Methods of Use
    Publication number: 20130336980
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: March 13, 2013
    Publication date: December 19, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiu Wu
  • ST2L Antagonists and Methods of Use
    Publication number: 20130287777
    Abstract: The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 31, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventors: Karen Duffy, Natalie Fursov, LeRoy Hall, Catherine Healy, Roberta Lamb, Jinquan Luo, Ravi Malaviya, Michael Naso, Michael Pratta, Mark Tornetta, John Wheeler, Sheng-Jiu Wu
  • Therapeutic compounds
    Publication number: 20060276491
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Application
    Filed: November 17, 2003
    Publication date: December 7, 2006
    Applicant: Parker Hughes Institute
    Inventors: Fatih Uckun, Elise Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • BTK inhibitors
    Publication number: 20060167090
    Abstract: The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors, including allergy treatments.
    Type: Application
    Filed: June 21, 2004
    Publication date: July 27, 2006
    Applicant: Parker Hughes Institute
    Inventors: Fatih Uckun, Ravi Malaviya
  • JAK-3 inhibitors for treating allergic disorders
    Publication number: 20050187233
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy, and others are described.
    Type: Application
    Filed: December 28, 2004
    Publication date: August 25, 2005
    Applicant: Parker Hughes Institute
    Inventors: Faith Uckun, Ravi Malaviya, Elise Sudbeck
  • Therapeutic compounds
    Publication number: 20040192711
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Application
    Filed: November 17, 2003
    Publication date: September 30, 2004
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • BTK inhibitors and methods for their identification and use
    Patent number: 6753348
    Abstract: The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors, including allergy treatments.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: June 22, 2004
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya
  • BTK inhibitors and methods for their identification and use
    Publication number: 20030144351
    Abstract: The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors, including allergy treatments.
    Type: Application
    Filed: April 2, 2002
    Publication date: July 31, 2003
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya